XORTX THERAPEUTICS INC (XRTX)
CA98420Q3061 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 95.00K | 3.82M | 13.92M | 126.46K | 58.61K | |||
| Cash Equivalents | 3.35M | 6.61M | N/A | N/A | N/A | |||
| Marketable Securities | N/A | N/A | 0.00 | 1.36M | 656.32K | |||
| Receivables | 60.71K | 81.75K | 37.99K | 43.66K | 15.47K | |||
| Other Current Assets | 560.41K | 379.62K | 936.51K | 0.00 | 84.84K | |||
| Total Current Assets | 4.07M | 10.90M | 14.87M | 1.54M | 815.25K | |||
| Non-Current Assets | ||||||||
| PPE Net | 23.93K | 92.68K | N/A | 0.00 | 340.00 | |||
| Investments And Advances | 1.20M | 1.19M | 1.18M | N/A | N/A | |||
| Intangibles | 175.25K | 199.83K | 188.87K | 174.98K | 272.39K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.40M | 1.48M | 1.37M | 174.98K | 272.73K | |||
| TOTAL ASSETS | 5.47M | 12.37M | 16.24M | 1.71M | 1.09M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 11.51K | 77.60K | N/A | 0.00 | 50.81K | |||
| Accrued Expenses | 87.61K | 151.41K | 213.97K | N/A | 544.09K | |||
| Accounts Payable | 195.81K | 1.29M | 302.72K | 772.32K | 607.39K | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 97.41K | |||
| Total Current Liabilities | 294.94K | 1.52M | 516.70K | 772.32K | 1.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 531.00K | 3.85M | 3.39M | N/A | N/A | |||
| Total Non-Current Liabilities | 531.00K | 3.85M | 3.39M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 825.94K | 5.38M | 3.91M | 772.32K | 1.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -12.39M | -9.50M | -2.44M | -6.00M | -6.76M | |||
| Additional Paid In Capital | N/A | N/A | N/A | 0.00 | 70.00K | |||
| Common Shares | 17.08M | 16.55M | 14.77M | 6.19M | 5.86M | |||
| Other Shareholders' Equity | -52.61K | 6.14M | 4.77M | 749.47K | 613.00K | |||
| Shares Outstanding | 2.00M | 1.67M | 1.44M | 768.30K | 5.36M | |||
| Tangible Book Value per Share | 2.23 | 4.07 | 8.42 | 0.99 | -0.09 | |||
| Total Shareholders' Equity | 4.64M | 7.00M | 12.34M | 938.12K | -211.72K | |||
| TOTAL LIABILITIES AND EQUITY | 5.47M | 12.37M | 16.24M | 1.71M | 1.09M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 13.80 | 7.15 | 28.78 | 1.99 | 0.63 | |||
| Return On Assets (ROA) | -39.47% | -62.38% | -7.50% | -56.08% | -57.87% | |||
| Return On Equity (ROE) | -46.49% | -110.32% | -9.87% | -102.26% | N/A | |||
All data in USD